Ensign Group, Inc ENSG
We take great care to ensure that the data presented and summarized in this overview for ENSIGN GROUP, INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ENSG
View all-
Black Rock Inc. New York, NY9.02MShares$1.3 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.49MShares$938 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.34MShares$482 Million2.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA2.46MShares$355 Million0.08% of portfolio
-
State Street Corp Boston, MA2.01MShares$290 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.36MShares$197 Million0.02% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.36MShares$196 Million0.78% of portfolio
-
Riverbridge Partners LLC1.2MShares$174 Million2.4% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.19MShares$172 Million0.04% of portfolio
-
Crewe Advisors LLC1.11MShares$161 Million18.59% of portfolio
Latest Institutional Activity in ENSG
Top Purchases
Top Sells
About ENSG
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Insider Transactions at ENSG
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Daren Shaw Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.42%
|
$290,000
$145.2 P/Share
|
|
Nov 06
2024
|
Barry Port Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+8.37%
|
-
|
|
Nov 06
2024
|
Chad Keetch CIO, EVP and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+4.02%
|
-
|
|
Nov 06
2024
|
Spencer Burton President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.9%
|
-
|
|
Nov 06
2024
|
Suzanne D. Snapper CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+1.83%
|
-
|
|
Nov 01
2024
|
Ann Scott Blouin Director |
SELL
Open market or private sale
|
Direct |
375
-1.75%
|
$58,125
$155.31 P/Share
|
|
Oct 25
2024
|
Barry Port Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,000
-3.59%
|
$310,000
$155.0 P/Share
|
|
Oct 25
2024
|
Barry Port Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.47%
|
$30,000
$15.93 P/Share
|
|
Oct 15
2024
|
Ann Scott Blouin Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+2.72%
|
-
|
|
Oct 15
2024
|
Daren Shaw Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+1.98%
|
-
|
|
Oct 15
2024
|
John O Agwunobi Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+8.19%
|
-
|
|
Oct 15
2024
|
Barry M Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+1.87%
|
-
|
|
Oct 15
2024
|
Swati Bargotra Abbott Director |
BUY
Grant, award, or other acquisition
|
Direct |
600
+3.47%
|
-
|
|
Sep 13
2024
|
Swati Bargotra Abbott Director |
SELL
Open market or private sale
|
Direct |
1,000
-5.86%
|
$152,000
$152.45 P/Share
|
|
Sep 10
2024
|
Christopher R. Christensen Executive Chairman |
BUY
Bona fide gift
|
Indirect |
13,721
+6.96%
|
-
|
|
Sep 10
2024
|
Christopher R. Christensen Executive Chairman |
SELL
Bona fide gift
|
Direct |
13,721
-52.25%
|
-
|
|
Sep 09
2024
|
Suzanne D. Snapper CFO |
SELL
Bona fide gift
|
Direct |
1,647
-0.65%
|
-
|
|
Aug 29
2024
|
Barry Port Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,618
-9.47%
|
$842,700
$150.0 P/Share
|
|
Aug 29
2024
|
Barry Port Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,618
+4.56%
|
$101,124
$18.66 P/Share
|
|
Aug 22
2024
|
Barry Port Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,500
-6.12%
|
$507,500
$145.0 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 78.5K shares |
|---|---|
| Bona fide gift | 52.9K shares |
| Acquisition or disposition by will or laws | 7.22K shares |
| Exercise of conversion of derivative security | 78.5K shares |
| Open market or private purchase | 0 shares |
| Open market or private sale | 203K shares |
|---|---|
| Payment of exercise price or tax liability | 10.2K shares |
| Bona fide gift | 69.6K shares |